Evidence map›Paper›PMID 31053615›Full record

ReviewGenetics2019

The RNA Polymerase II Core Promoter in

Long Vo Ngoc, George A Kassavetis, James T Kadonaga

Abstract readReview
In one paragraph

Review in Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed.

  1. Embedded CRISPRi Enhances Gene-Silencing Efficiency in Drosophila.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Cis-Regulatory Elements in Mammals.International journal of molecular sciences · 2023
    Review
  19. Article
  20. The N-Terminal Part ofInternational journal of molecular sciences · 2023
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Long Vo NgocSection of Molecular Biology, University of California, San Diego, La Jolla, California 92093-0347.
George A KassavetisSection of Molecular Biology, University of California, San Diego, La Jolla, California 92093-0347.
James T KadonagaSection of Molecular Biology, University of California, San Diego, La Jolla, California 92093-0347 jkadonaga@ucsd.edu.

Funding

Mechanisms of Eukaryotic Gene RegulationR35GM118060 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI James T. Kadonaga · 2016 to 2026
$7.5M
NIGMS NIH HHS R35 GM118060
6 · The paper itself

Abstract

Transcription by RNA polymerase II initiates at the core promoter, which is sometimes referred to as the "gateway to transcription." Here, we describe the properties of the RNA polymerase II core promoter in

Indexed as

Promoter Regions, GeneticTranscription, GeneticAnimalsDrosophilaDrosophila ProteinsRNA Polymerase IITranscriptional ActivationDrosophila ProteinsRNA Polymerase IIcore promotercore promoter elementsFlyBookRNA polymerase IIsequence-specific transcription factorsTBPTBP-related factors

Identifiers

PMID31053615
PMCPMC6499525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.